CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

Clin Mol Hepatol. 2015;21(1):49-59. Published online 2015 March 25 DOI: https://doi.org/10.3350/cmh.2015.21.1.49

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

Clinical and Molecular Hepatology. 2015;21(1):49

Link1 Link2 Link3

Silibinin sensitizes CD133+ hepatocellular carcinoma cells to cisplatin treatment through suppression of OPA1

Jikang Yang, Zhiyuan Xing

. 2020;

Link1 Link2

SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

Savita Mishra, Sandhya Hora, Vibha Shukla, Mukul Das, Harsha Kharkwal, Deepshikha Pande Katare

International Journal of Applied Pharmaceutics. 2018;10(5):117

Link1 Link2 Link3

Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance

Xinhua Zou, Qingyu Xu, Ran You, Guowen Yin

Journal of Hepatocellular Carcinoma. 2023;Volume 10:267-279

Link1 Link2

Celecoxib enhances the regulation of sorafenib on the expression of prognostic genes in hepatocellular carcinoma

Wang Gu, Chao Zhang

. 2022;

Link1 Link2

Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib

Zhonghao Jiang, Chaoliu Dai

Journal of Hepatocellular Carcinoma. 2023;Volume 10:257-266

Link1 Link2

Inhibiting CBX4 efficiently suppress YAP nucleus translocation in hepatocellular carcinoma cells to protect against sorafenib resistance

wei zhao, BO Ma, Zhihua Tian, Haibo Han, Jintian Tang, Bin Dong, Guo An, Baoshan Cao, Boqing Wang

. 2020;

Link1 Link2

Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study

Mai M. Abdelmageed, Reem N. El-Naga, Ebtehal El-Demerdash, Mohamed M. Elmazar

Scientific Reports. 2016;6(1):

Link1

Link2 Link3

Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival

Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, Na Shang, Annika Dalheim, Xianzhong Ding, Scott J. Cotler, Mitchell F. Denning, Michael I. Nishimura, Peter Breslin, Wei Qiu

Hepatology Communications. 2018;2(6):732-746

Link1 Link2 Link3 Link4

The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib

Xue Zhang, Ji-Gang Zhang, Wan Mu, He-Ming Zhou, Gao-Lin Liu, Qin Li

Phytomedicine. 2021;92:153740

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.